Literature DB >> 2141604

A new transient activator of phosphofructokinase during initiation of rapid glycolysis in brain.

S Ogushi1, J W Lawson, G P Dobson, R L Veech, K Uyeda.   

Abstract

The tissue contents of previously known allosteric effectors of brain phosphofructokinase (EC 2.7.1.11) (PFK) and the kinetic behavior of isolated PFK were investigated during the initiation of rapid glycolytic flux in freeze-blown rat brain. Comparing 0- with 5-s brains revealed that there was a 4-fold drop in total tissue content of Fru-6-P and a 5.6-fold increase in Fru-1,6-P2 consistent with activation of PFK. Additionally, analysis of brain content showed a 15-fold increase in AMP, a 3-fold decrease in ATP, a 3-fold decrease in Pi, and a 1.6-fold increase in NH4+. There was no change in Fru-2,6-P2, H+, citrate, or Glc-1,6-P2 or the kinetic profiles of isolated PFK for ATP inhibition or Fru-2,6-P2 activation. We concluded that the observed change in PFK activity could be accounted for only partially by changes in the concentrations of adenine nucleotides and other known effectors. High performance liquid chromatography fractions of extracts obtained from 5-s brains showed the activator with a mobility identical to ribose 1,5-P2 and gave 2 nmol/g (wet weight) at 0 s, 10 nmol/g at 5 s, and 2 nmol/g at 20 s. Assay of PFK in the presence of effectors determined to be in tissue at 5 s showed that addition of 10 nmol/ml ribose 1,5-P2 gave a 4-fold activation of PFK. Based on the rapidity of its formation, its potency of activation, and its similarity in chemical properties to authentic ribose 1,5-P2, we conclude that ribose 1,5-P2 served as the initial activator of PFK in brain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2141604

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in rat brain.

Authors:  F Ventura; J L Rosa; S Ambrosio; J Gil; R Bartrons
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

Review 2.  Response to 'comment on recent modeling studies of astrocyte-neuron metabolic interactions': much ado about nothing.

Authors:  Silvia Mangia; Mauro DiNuzzo; Federico Giove; Anthony Carruthers; Ian A Simpson; Susan J Vannucci
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-23       Impact factor: 6.200

3.  Measuring in vivo metabolite levels in brain.

Authors:  David F Wilson
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

Review 4.  How glycogen sustains brain function: A plausible allosteric signaling pathway mediated by glucose phosphates.

Authors:  Mauro DiNuzzo
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-17       Impact factor: 6.200

5.  Regulation of brain 6-phosphofructo-1-kinase: effects of aging, fructose-2,6-bisphosphate, and regional subunit distribution.

Authors:  T P Kasten; Y Mhaskar; G A Dunaway
Journal:  Mol Cell Biochem       Date:  1993-03-10       Impact factor: 3.396

Review 6.  Metabolomic and Imaging Mass Spectrometric Assays of Labile Brain Metabolites: Critical Importance of Brain Harvest Procedures.

Authors:  Gerald A Dienel
Journal:  Neurochem Res       Date:  2020-09-19       Impact factor: 3.996

7.  Kinetic Characterisation of Phosphofructokinase Purified from Setaria cervi: A Bovine Filarial Parasite.

Authors:  Bechan Sharma
Journal:  Enzyme Res       Date:  2011-09-15

8.  Modulation of phosphofructokinase (PFK) from Setaria cervi, a bovine filarial parasite, by different effectors and its interaction with some antifilarials.

Authors:  Bechan Sharma
Journal:  Parasit Vectors       Date:  2011-12-07       Impact factor: 3.876

Review 9.  Iron and aluminum homeostasis in neural disorders.

Authors:  J G Joshi; M Dhar; M Clauberg; V Chauthaiwale
Journal:  Environ Health Perspect       Date:  1994-09       Impact factor: 9.031

10.  The cellular and compartmental profile of mouse retinal glycolysis, tricarboxylic acid cycle, oxidative phosphorylation, and ~P transferring kinases.

Authors:  Elda M Rueda; Jerry E Johnson; Anand Giddabasappa; Anand Swaroop; Matthew J Brooks; Irena Sigel; Shawnta Y Chaney; Donald A Fox
Journal:  Mol Vis       Date:  2016-07-23       Impact factor: 2.367

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.